Accessibility Menu
Biomea Fusion logo

Biomea Fusion

(NASDAQ) BMEA

Current Price$1.10
Market Cap$82.72M
Since IPO (2021)-94%
5 YearN/A
1 Year-60%
1 Month-18%

Biomea Fusion Financials at a Glance

Market Cap

$82.72M

Revenue (TTM)

$0.00

Net Income (TTM)

$95.71M

EPS (TTM)

$-2.39

P/E Ratio

-0.49

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.10

Volume

1,540,354.837

Open

$1.15

Previous Close

$1.09

Daily Range

$1.09 - $1.16

52-Week Range

$0.87 - $3.08

BMEA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biomea Fusion

Industry

Biotechnology

Employees

42

CEO

Michael J. M. Hitchcock, PhD

Headquarters

Redwood City, CA 94063, US

BMEA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-209%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-2.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$82.72M

Shares Outstanding

70.70M

Volume

1.54M

Short Interest

0.00%

Avg. Volume

1.09M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$144.07M

EBITDA

$142.32M

Operating Cash Flow

$119.89M

Capital Expenditure

$362.00K

Free Cash Flow

$120.26M

Cash & ST Invst.

$58.28M

Total Debt

$8.77M

Biomea Fusion Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$400.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$82.72M

N/A

Market Cap/Employee

$1.05M

N/A

Employees

79

N/A

Net Income

$16.41M

+50.0%

EBITDA

$15.98M

+52.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$39.77M

-49.3%

Accounts Receivable

$22.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$6.09M

-11.4%

Short Term Debt

$787.00K

-70.8%

Return on Assets

-1.73%

N/A

Return on Invested Capital

-2.57%

N/A

Free Cash Flow

$12.18M

+52.1%

Operating Cash Flow

$12.18M

+51.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PMVPPMV Pharmaceuticals, Inc.
$1.50+0.67%
ADVMAdverum Biotechnologies, Inc.
$4.36+0.00%
CAMPCAMP4 Therapeutics Corporation
$5.16-3.19%
RPTXRepare Therapeutics Inc.
$2.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
SOFISoFi Technologies
$17.08-0.01%

Questions About BMEA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.